Marvin Slepian

Marvin Slepian

Director/Board Member at
Strike Photonics, Inc.
70 year
Health Technology
Consumer Services
Electronic Technology

Profile

Marvin J.
Slepian
is the founder of Focal, Inc. (1991), Hansen Medical, Inc. (2002), MC10, Inc. (2008), EndoTex Interventional Systems, Inc. (1995), Angiotrax, Inc. (1997), and SynCardia Systems LLC (2001).
At SynCardia Systems LLC, Dr. Slepian held the title of Director, Chief Scientific & Medical Officer from 2001 to 2013.
Current jobs include Director at Regenesis Biomedical, Inc., Director-Tissue Engineering & Professor at the University of Arizona since 2011, Chief Medical Officer & Director at Strike Photonics, Inc., and Independent Director at Nuvox Pharma LLC.
Former jobs include Director at CardioGenesis Corp.
from 2009 to 2011, Director at Organ Transport Systems, Inc., Director at ThromboVision, Inc., and Chief Medical Officer at Cardio Ventures Ltd. from 2009 to 2011.
Education includes an undergraduate degree from Princeton University conferred in 1977 and a doctorate from The University of Cincinnati College of Medicine.

Marvin Slepian active positions

CompaniesPositionStart
Corporate Officer/Principal 30/07/2009
Director/Board Member -
Director/Board Member -
Director/Board Member -

Former positions of Marvin Slepian

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 01/01/2011
Founder -
Founder -
Angiotrax, Inc.
Founder -
HANSEN MEDICAL, INC. Founder -
See the detail of Marvin Slepian's experience

Training of Marvin Slepian

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Consumer Services

Consumer Services

Consumer Services

Finance

Angiotrax, Inc.

Commercial Services

Electronic Technology

  1. Stock Market
  2. Insiders
  3. Marvin Slepian